Biogen sales face pressure from slow uptake of Alzhiemer's drug
Go back to Biogen sales face pressure from slow uptake of Alzhiemer's drug| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 228.84 +1.24 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.60 | 52 Week High | $333.65 | |||
| Open | $225.87 | 52 Week Low | $223.02 | |||
| Day High | $229.62 | P/E | 29.30 | |||
| Day Low | $225.51 | EPS | $7.81 | |||
| Volume | 344,338 | |||||
